Gene therapy improves symptoms for patients with ‘no-option’ treatment-resistant angina
Gene therapy improved exercise capacity and blood flow and reduced chest pain occurrence and nitroglycerine use for patients with advanced ischemic heart disease, a speaker reported. The results of the small, single-arm, open-label, phase 2 EXACT trial were presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions and simultaneously published in Circulation: